Updated interim analysis (IA) of COU-AA-302, a randomized phase III study of abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) without prior chemotherapy Meeting Abstract

  

Authors:	Rathkopf, D. E.; Smith, M. R.; De Bono, J. S.; Logothetis, C.; Shore, N. D.; De Souza, P. L.; Fizazi, K.; Mulders, P.; Mainwaring, P. N.; Hainsworth, J. D.; Beer, T. M.; North, S. A.; Fradet, Y.; Griffin, T. W.; Park, Y. C.; Kheoh, T. S.; Small, E. J.; Scher, H. I.; Molina, A.; Ryan, C. J.
Abstract Title:	Updated interim analysis (IA) of COU-AA-302, a randomized phase III study of abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) without prior chemotherapy
Meeting Title:	2013 Genitourinary Cancers Symposium
Journal Title:	Journal of Clinical Oncology
Volume:	31
Issue:	6 Suppl.
Meeting Dates:	2013 Feb 14-16
Meeting Location:	Orlando, FL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2013-02-20
Language:	English
ACCESSION:	WOS:000333679600009
PROVIDER:	wos
DOI:	10.1200/jco.2013.31.6_suppl.5
Notes:	Meeting Abstract: 5 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/128864